Early decrease of forced vital capacity is a good prediction tool for prognosis in patients with idiopathic pulmonary fibrosis

C. Sepulveda, C. Azocar, M. Florenzano, G. Cavada, A. Undurraga (Santiago/RM, Chile)

Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Session: Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Session type: Thematic Poster Session
Number: 3477
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Sepulveda, C. Azocar, M. Florenzano, G. Cavada, A. Undurraga (Santiago/RM, Chile). Early decrease of forced vital capacity is a good prediction tool for prognosis in patients with idiopathic pulmonary fibrosis. Eur Respir J 2008; 32: Suppl. 52, 3477

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
Source: Eur Respir J 2010; 35: 830-836
Year: 2010



Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J, 52 (2) 1702593; 10.1183/13993003.02593-2017
Year: 2018



Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes
Source: Eur Respir Rev 2012; 21: 161-167
Year: 2012



Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017

Spirometric evaluation of idiopathic pulmonary fibrosis (IPF): forced or slow vital capacity?
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019


Does rapid decline predict poor prognosis?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007


A simple assessment of dyspnea as a prognostic indicator in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010


Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Hyaluroman syntehase-2 over expression has impact in the evolution and on the prognosis of idiopathic pulmonary fibrosis patients
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012

Evaluation of recently validated non-invasive formula using basic lung functions as a new screening tool for pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009


A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
Source: Eur Respir J 2010; 36: 1067-1072
Year: 2010



Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 204-212
Year: 2004



Is age a predictor in prognosis of patients with idiopathic pulmonary fibrosis?
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Percent predicted forced vital capacity (FVC) is a reliable, valid, and responsive measure of clinical status in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis
Year: 2010

Does the questionnaire “human activity profile” assess functional capacity in patients with idiopathic pulmonary fibrosis?
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021


Forced vital capacity decreases rapidly in patients with idiopathic upper lobe-dominant pulmonary fibrosis
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011


A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (1) 00096-2016; 10.1183/23120541.00096-2016
Year: 2017



Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence?
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015


Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011

Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
Source: Eur Respir J 2011; 37: 176-183
Year: 2011